Boundless Bio Inc (BOLD) Stock Price, Quote & News - Mboum

Company Profile

Boundless Bio, Inc., a clinical-stage oncology company, develops interrogating extrachromosomal DNA (ecDNA) directed therapies for treating patients with oncogene amplified cancers. Its lead product candidate is BBI-940, an ecDNA-directed therapeutic candidate (ecDTx) that is in Phase 1/2 clinical trial in patients with estrogen receptor positive and human epidermal growth factor receptor 2 negative breast cancer, as well as patients with triple-negative breast cancer luminal androgen receptor s...

Industry: Biotechnology

Sector: Healthcare

Phone: 858 766 9912

Website: boundlessbio.com

Address:

10955 Alexandria Way, Suite 100, San Diego, United States

Golibajje Apr. 15 at 10:57 PM

$BOLD Along with this $BOLT is another lottery ticket in the making! It is trading nearly 1/4th of cash (low float with 1.9m shares.. $9M mkt cap vs $31M cash).. they have phase 1 results in Q3.. disruptive treatment in BILLION $$ mkt! Could go 500%+ if the results are positive! $ZNTL $ALMS

0 · Reply

Golibajje Apr. 15 at 3:54 PM

$BOLD breakout in 2-3 days!!

0 · Reply

OneandOnly001 Apr. 15 at 1:14 PM

$AGAE $BOLD $RETO 🤑🤑🤑

0 · Reply

OneandOnly001 Apr. 15 at 12:40 PM

$RETO $AGAE $BOLD 🔥🔥🔥 https://micro-stock-scout.replit.app/

0 · Reply

revuelto Apr. 14 at 9:20 PM

$BOLD = GOLD 🎉

0 · Reply

OneandOnly001 Apr. 14 at 8:44 PM

$GBR $BOLD ❤️❤️❤️❤️ https://micro-stock-scout.replit.app/

0 · Reply

vu_jade Apr. 14 at 7:52 PM

$BOLD & the beautiful Everyone will saybthey bought at $1 We have receipts .. See you at $5, $8, $10 & $16

1 · Reply

revuelto Apr. 14 at 6:21 PM

$BOLD there’s a reason for that 5.5m volume..welcome to the la la land soon 🎉

0 · Reply

Galaxytrader Apr. 14 at 6:17 PM

$BOLD $3 by tomorrow!

0 · Reply

OneandOnly001 Apr. 14 at 4:37 PM

$BOLD $ARAI $SMTK https://micro-stock-scout.replit.app/

0 · Reply

Latest News on BOLD

Boundless Bio Announces Upcoming Presentation of Oral Kinesin Degrader Program at the American Association for Cancer Research Annual Meeting 2026

Mar 17, 2026, 4:52 PM EDT - 4 weeks ago

Boundless Bio Announces Upcoming Presentation of Oral Kinesin Degrader Program at the American Association for Cancer Research Annual Meeting 2026

Boundless Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights

Mar 9, 2026, 7:00 AM EDT - 5 weeks ago

Boundless Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights

Boundless Bio to Participate in the Leerink Global Healthcare Conference

Mar 4, 2026, 7:00 AM EST - 6 weeks ago

Boundless Bio to Participate in the Leerink Global Healthcare Conference

Boundless Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

Feb 5, 2026, 7:00 AM EST - 2 months ago

Boundless Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

Boundless Bio Advances Novel Kinesin Degrader Program BBI-940 and Extends Cash Runway

Jan 20, 2026, 7:00 AM EST - 3 months ago

Boundless Bio Advances Novel Kinesin Degrader Program BBI-940 and Extends Cash Runway

Boundless Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference

Nov 24, 2025, 7:00 AM EST - 5 months ago

Boundless Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference

Boundless Bio Reports Third Quarter 2025 Financial Results and Business Highlights

Nov 5, 2025, 7:00 AM EST - 5 months ago

Boundless Bio Reports Third Quarter 2025 Financial Results and Business Highlights

Boundless Bio Announces Upcoming Presentation at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Oct 13, 2025, 4:05 PM EDT - 6 months ago

Boundless Bio Announces Upcoming Presentation at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Boundless Bio Reports Second Quarter 2025 Financial Results and Business Highlights

Aug 5, 2025, 7:00 AM EDT - 9 months ago

Boundless Bio Reports Second Quarter 2025 Financial Results and Business Highlights

Boundless Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

Jun 5, 2025, 4:58 PM EDT - 11 months ago

Boundless Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

Boundless Bio Announces Portfolio Prioritization and Runway Extension

May 23, 2025, 4:01 PM EDT - 11 months ago

Boundless Bio Announces Portfolio Prioritization and Runway Extension

Boundless Bio Reports First Quarter 2025 Financial Results and Business Highlights

May 9, 2025, 7:00 AM EDT - 1 year ago

Boundless Bio Reports First Quarter 2025 Financial Results and Business Highlights

Boundless Bio to Participate in the Needham Virtual Healthcare Conference

Apr 3, 2025, 7:00 AM EDT - 1 year ago

Boundless Bio to Participate in the Needham Virtual Healthcare Conference

Boundless Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

Mar 27, 2025, 7:00 AM EDT - 1 year ago

Boundless Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

Boundless Bio to Participate in the Leerink Global Healthcare Conference

Feb 26, 2025, 7:00 AM EST - 1 year ago

Boundless Bio to Participate in the Leerink Global Healthcare Conference

Boundless Bio Appoints Robert Doebele, M.D., Ph.D., as Chief Medical Officer

Feb 3, 2025, 10:00 AM EST - 1 year ago

Boundless Bio Appoints Robert Doebele, M.D., Ph.D., as Chief Medical Officer

Boundless Bio Announces Pipeline and Leadership Updates

Dec 12, 2024, 4:01 PM EST - 1 year ago

Boundless Bio Announces Pipeline and Leadership Updates

Boundless Bio to Participate in the Piper Sandler Healthcare Conference

Nov 25, 2024, 7:00 AM EST - 1 year ago

Boundless Bio to Participate in the Piper Sandler Healthcare Conference

Boundless Bio Reports Third Quarter 2024 Financial Results and Business Highlights

Nov 7, 2024, 4:01 PM EST - 1 year ago

Boundless Bio Reports Third Quarter 2024 Financial Results and Business Highlights

Boundless Bio to Participate in the 2024 Guggenheim Global Healthcare Conference

Nov 5, 2024, 7:00 AM EST - 1 year ago

Boundless Bio to Participate in the 2024 Guggenheim Global Healthcare Conference

Boundless Bio to Participate in the 2024 Cantor Global Healthcare Conference

Sep 11, 2024, 7:00 AM EDT - 1 year ago

Boundless Bio to Participate in the 2024 Cantor Global Healthcare Conference

Boundless Bio Provides Business Updates Focused on Key Value Drivers and Reports Second Quarter 2024 Financial Results

Aug 12, 2024, 4:01 PM EDT - 1 year ago

Boundless Bio Provides Business Updates Focused on Key Value Drivers and Reports Second Quarter 2024 Financial Results

Boundless Bio to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Jun 5, 2024, 7:00 AM EDT - 2 years ago

Boundless Bio to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Boundless Bio Reports First Quarter 2024 Financial Results and Corporate Highlights

May 13, 2024, 7:00 AM EDT - 2 years ago

Boundless Bio Reports First Quarter 2024 Financial Results and Corporate Highlights

Boundless Bio to Present at the Citizens JMP Life Sciences Conference 2024

May 6, 2024, 8:00 AM EDT - 2 years ago

Boundless Bio to Present at the Citizens JMP Life Sciences Conference 2024

Boundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene Amplifications

Apr 11, 2024, 8:00 AM EDT - 2 years ago

Boundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene Amplifications

Boundless Bio Presents Preclinical and Clinical Pharmacodynamic Data on its Lead Extrachromosomal DNA (ecDNA)-Directed Therapy, BBI-355, at the American Association for Cancer Research Annual Meeting 2024

Apr 8, 2024, 8:00 AM EDT - 2 years ago

Boundless Bio Presents Preclinical and Clinical Pharmacodynamic Data on its Lead Extrachromosomal DNA (ecDNA)-Directed Therapy, BBI-355, at the American Association for Cancer Research Annual Meeting 2024

Boundless Bio Announces Pricing of Initial Public Offering

Mar 27, 2024, 6:55 PM EDT - 2 years ago

Boundless Bio Announces Pricing of Initial Public Offering

Golibajje Apr. 15 at 10:57 PM

$BOLD Along with this $BOLT is another lottery ticket in the making! It is trading nearly 1/4th of cash (low float with 1.9m shares.. $9M mkt cap vs $31M cash).. they have phase 1 results in Q3.. disruptive treatment in BILLION $$ mkt! Could go 500%+ if the results are positive! $ZNTL $ALMS

0 · Reply

Golibajje Apr. 15 at 3:54 PM

$BOLD breakout in 2-3 days!!

0 · Reply

OneandOnly001 Apr. 15 at 1:14 PM

$AGAE $BOLD $RETO 🤑🤑🤑

0 · Reply

OneandOnly001 Apr. 15 at 12:40 PM

$RETO $AGAE $BOLD 🔥🔥🔥 https://micro-stock-scout.replit.app/

0 · Reply

revuelto Apr. 14 at 9:20 PM

$BOLD = GOLD 🎉

0 · Reply

OneandOnly001 Apr. 14 at 8:44 PM

$GBR $BOLD ❤️❤️❤️❤️ https://micro-stock-scout.replit.app/

0 · Reply

vu_jade Apr. 14 at 7:52 PM

$BOLD & the beautiful Everyone will saybthey bought at $1 We have receipts .. See you at $5, $8, $10 & $16

1 · Reply

revuelto Apr. 14 at 6:21 PM

$BOLD there’s a reason for that 5.5m volume..welcome to the la la land soon 🎉

0 · Reply

Galaxytrader Apr. 14 at 6:17 PM

$BOLD $3 by tomorrow!

0 · Reply

OneandOnly001 Apr. 14 at 4:37 PM

$BOLD $ARAI $SMTK https://micro-stock-scout.replit.app/

0 · Reply

OneandOnly001 Apr. 14 at 4:35 PM

0 · Reply

OneandOnly001 Apr. 14 at 4:34 PM

$BOLD $RETO 💰💰💰 https://micro-stock-scout.replit.app/

0 · Reply

OneandOnly001 Apr. 14 at 4:30 PM

$ARAI $BOLD 🔥🔥 https://micro-stock-scout.replit.app/

0 · Reply

OneandOnly001 Apr. 14 at 3:23 PM

$BOLD $HOTH $HUBC 🔥🔥🔥

0 · Reply

revuelto Apr. 14 at 3:21 PM

$BOLD how about $2+ ah today? 🐋

0 · Reply

OneandOnly001 Apr. 14 at 2:51 PM

$HUBC $BOLD 🔥🔥🔥 https://micro-stock-scout.replit.app/

0 · Reply

Dirk1969 Apr. 14 at 2:49 PM

$BOLD 👇🏽

0 · Reply

intrader Apr. 14 at 2:47 PM

$BOLD I took 90% off here. Let the rest run.

0 · Reply

OneandOnly001 Apr. 14 at 2:34 PM

$BOLD 🔥🔥🔥

0 · Reply

Play_Nice69 Apr. 14 at 2:26 PM

$BOLD If this breaks 1.80…

0 · Reply

intrader Apr. 14 at 2:26 PM

$BOLD I'm in, Target $2.00+

0 · Reply

nf04 Apr. 14 at 2:21 PM

$BOLD bought on Friday for 1.15 in anticipation of the upcoming AACR poster. Early leak?

1 · Reply